The European Commission has struck deals with drugmakers Roche and Merck KGaA to secure supplies of experimental treatments for COVID-19, a Commission source told Reuters on Wednesday. The deals cover Roche’s arthritis medicine RoActemra and Merck’s multiple sclerosis drug Rebif – both seen as potential treatments for COVID-19 – and …
Read More »